AU4261697A – Compounds and methods
– Google Patents
AU4261697A – Compounds and methods
– Google Patents
Compounds and methods
Info
Publication number
AU4261697A
AU4261697A
AU42616/97A
AU4261697A
AU4261697A
AU 4261697 A
AU4261697 A
AU 4261697A
AU 42616/97 A
AU42616/97 A
AU 42616/97A
AU 4261697 A
AU4261697 A
AU 4261697A
AU 4261697 A
AU4261697 A
AU 4261697A
Authority
AU
Australia
Prior art keywords
compounds
methods
Prior art date
1996-09-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42616/97A
Inventor
Robert A Daines
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-09-09
Filing date
1997-09-09
Publication date
1998-03-26
1997-09-09
Application filed by SmithKline Beecham Corp
filed
Critical
SmithKline Beecham Corp
1998-03-26
Publication of AU4261697A
publication
Critical
patent/AU4261697A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P11/00—Drugs for disorders of the respiratory system
A61P11/02—Nasal agents, e.g. decongestants
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P11/00—Drugs for disorders of the respiratory system
A61P11/06—Antiasthmatics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P17/00—Drugs for dermatological disorders
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P19/00—Drugs for skeletal disorders
A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/04—Centrally acting analgesics, e.g. opioids
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/06—Antimigraine agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P3/00—Drugs for disorders of the metabolism
A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P37/00—Drugs for immunological or allergic disorders
A61P37/08—Antiallergic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C233/00—Carboxylic acid amides
C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C233/00—Carboxylic acid amides
C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
C07C233/66—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C233/00—Carboxylic acid amides
C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C233/00—Carboxylic acid amides
C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C233/00—Carboxylic acid amides
C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
C07C233/80—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C233/00—Carboxylic acid amides
C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C255/00—Carboxylic acid nitriles
C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
C07D209/04—Indoles; Hydrogenated indoles
C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
C07D209/04—Indoles; Hydrogenated indoles
C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D213/72—Nitrogen atoms
C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D215/38—Nitrogen atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
C07D223/16—Benzazepines; Hydrogenated benzazepines
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D249/14—Nitrogen atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D261/14—Nitrogen atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
C07D277/62—Benzothiazoles
C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
C07D277/82—Nitrogen atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 – C07D283/00
C07D285/01—Five-membered rings
C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
C07D285/135—Nitrogen atoms
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
C07D295/182—Radicals derived from carboxylic acids
C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
C07C2602/00—Systems containing two condensed rings
C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
C07C2602/04—One of the condensed rings being a six-membered aromatic ring
C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
AU42616/97A
1996-09-09
1997-09-09
Compounds and methods
Abandoned
AU4261697A
(en)
Applications Claiming Priority (5)
Application Number
Priority Date
Filing Date
Title
US2569096P
1996-09-09
1996-09-09
US60025690
1996-09-09
US4801297P
1997-05-29
1997-05-29
US60048012
1997-05-29
PCT/US1997/015931
WO1998009630A1
(en)
1996-09-09
1997-09-09
Compounds and methods
Publications (1)
Publication Number
Publication Date
AU4261697A
true
AU4261697A
(en)
1998-03-26
Family
ID=26700045
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU42616/97A
Abandoned
AU4261697A
(en)
1996-09-09
1997-09-09
Compounds and methods
Country Status (5)
Country
Link
EP
(1)
EP0934068A1
(en)
JP
(1)
JP2002511836A
(en)
AU
(1)
AU4261697A
(en)
CA
(1)
CA2264942A1
(en)
WO
(1)
WO1998009630A1
(en)
Families Citing this family (30)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US6780883B2
(en)
*
1998-11-05
2004-08-24
Warner-Lambert Company
Amide inhibitors of microsomal triglyceride transfer protein
US6844367B1
(en)
1999-09-17
2005-01-18
Millennium Pharmaceuticals, Inc.
Benzamides and related inhibitors of factor Xa
DE19952147A1
(en)
1999-10-29
2001-05-03
Boehringer Ingelheim Pharma
New cyclopropanes, pharmaceutical compositions containing these compounds and process for their preparation
CA2401778C
(en)
2000-02-29
2010-12-21
Cor Therapeutics, Inc.
Benzamides and related inhibitors of factor xa
WO2003104236A1
(en)
2002-06-01
2003-12-18
Bristol-Myers Squibb Company
Calcitonin gene related peptide receptor antagonists
US7842808B2
(en)
2002-06-05
2010-11-30
Bristol-Myers Squibb Company
Anti-migraine spirocycles
US7220862B2
(en)
2002-06-05
2007-05-22
Bristol-Myers Squibb Company
Calcitonin gene related peptide receptor antagonists
MXPA05001649A
(en)
2002-08-12
2005-05-27
Birkir Sveinsson
Use of cgrp antagonist compounds for treatment of psoriasis.
US7569578B2
(en)
2003-12-05
2009-08-04
Bristol-Meyers Squibb Company
Heterocyclic anti-migraine agents
AU2003297694A1
(en)
2003-12-05
2005-08-12
Bristol-Myers Squibb Company
Calcitonin gene related peptide receptor antagonists
US7544803B2
(en)
*
2004-01-23
2009-06-09
Amgen Inc.
Vanilloid receptor ligands and their use in treatments
TW200533398A
(en)
2004-03-29
2005-10-16
Bristol Myers Squibb Co
Novel therapeutic agents for the treatment of migraine
US7384931B2
(en)
2004-11-03
2008-06-10
Bristol-Myers Squibb Company
Constrained compounds as CGRP-receptor antagonists
US7384930B2
(en)
2004-11-03
2008-06-10
Bristol-Myers Squibb Company
Constrained compounds as CGRP-receptor antagonists
US7449586B2
(en)
2004-12-03
2008-11-11
Bristol-Myers Squibb Company
Processes for the preparation of CGRP-receptor antagonists and intermediates thereof
US7834007B2
(en)
2005-08-25
2010-11-16
Bristol-Myers Squibb Company
CGRP antagonists
SI2380592T1
(en)
2005-11-14
2018-06-29
Teva Pharmaceuticals International Gmbh
Antagonist antibody directed against calcitonin gene-related peptide
US8524907B2
(en)
2006-11-02
2013-09-03
Millennium Pharmaceuticals, Inc.
Methods of synthesizing pharmaceutical salts of a factor Xa inhibitor
EP2265287B1
(en)
2008-03-04
2018-09-05
Teva Pharmaceuticals International GmbH
Methods of treating chronic pain
UA105182C2
(en)
2008-07-03
2014-04-25
Ньюрексон, Інк.
Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
AU2010288194B2
(en)
2009-08-28
2013-08-29
Teva Pharmaceuticals International Gmbh
Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
CN107586338B
(en)
2011-05-20
2021-09-17
H.伦德贝克公司
anti-CGRP compositions and uses thereof
CN108359008B
(en)
2011-05-20
2022-03-29
H.伦德贝克公司
Use of anti-CGRP or anti-CGRP-R antibodies or antibody fragments for the treatment or prevention of chronic and acute forms of diarrhea
BR112013029959A8
(en)
2011-05-20
2021-09-08
Alderbio Holdings Llc
Anti-cgrp and anti-cgrpr antibodies and their use to prevent or inhibit photophobia or aversion to light, pharmaceutical composition comprising said antibodies, as well as nucleic acid sequence and recombinant cell
EP2844345B1
(en)
2012-05-04
2022-08-03
The United States of America, as Represented by The Secretary, Department of Health and Human Services
Modulators of the relaxin receptor 1
US10556945B2
(en)
2014-03-21
2020-02-11
Teva Pharmaceuticals International Gmbh
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
PE20220337A1
(en)
2014-03-21
2022-03-14
Teva Pharmaceuticals Int Gmbh
ANTAGONIST ANTIBODIES DIRECTED AGAINST THE CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING THE SAME
JP6937368B2
(en)
2016-09-23
2021-09-22
テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー
How to treat intractable migraine
US11433119B2
(en)
2016-11-18
2022-09-06
Nepsone Ehf
Methods of treating inflammatory skin disorders
MA54704A
(en)
2019-01-08
2022-04-13
H Lundbeck As
ACUTE AND RAPID TREATMENT OF HEADACHES USING ANTI-CGRP ANTIBODIES
1997
1997-09-09
WO
PCT/US1997/015931
patent/WO1998009630A1/en
not_active
Application Discontinuation
1997-09-09
JP
JP51299498A
patent/JP2002511836A/en
active
Pending
1997-09-09
AU
AU42616/97A
patent/AU4261697A/en
not_active
Abandoned
1997-09-09
CA
CA002264942A
patent/CA2264942A1/en
not_active
Abandoned
1997-09-09
EP
EP97940951A
patent/EP0934068A1/en
not_active
Withdrawn
Also Published As
Publication number
Publication date
WO1998009630A1
(en)
1998-03-12
JP2002511836A
(en)
2002-04-16
EP0934068A1
(en)
1999-08-11
CA2264942A1
(en)
1998-03-12
Similar Documents
Publication
Publication Date
Title
AU9790198A
(en)
1999-04-27
Compounds and methods
AU4261697A
(en)
1998-03-26
Compounds and methods
AU4040197A
(en)
1998-02-09
Microturbomachinery
AU3387997A
(en)
1998-01-07
Autonotification
AU2845197A
(en)
1998-01-15
Cycloalkano-pyridines
AU4945197A
(en)
1998-05-11
Aminothiophenecarboxamides
AU4013397A
(en)
1998-03-06
Arylalkanoylpyridazines
AU4176997A
(en)
1998-04-02
3-alkyl-3-phenyl-piperidines
AU2684197A
(en)
1998-01-15
Handleset
AU5754898A
(en)
1998-07-03
Ussd-positioning
AU4218597A
(en)
1998-04-24
Superseat
AU2090897A
(en)
1997-09-16
Hydroxyhexahydropyridazines
AU5556998A
(en)
1998-07-03
3-amino-1-cyanophenyl-uracils
AU5221598A
(en)
1998-05-15
Sweet-toy
AU686068B2
(en)
1998-01-29
Cremators
AU2237197A
(en)
1997-09-10
Fishing-lure
AU4332497A
(en)
1998-04-02
Endo-beta-galactosidase
AU5983798A
(en)
1998-07-15
Heterocyclyluracils
AU5754598A
(en)
1998-07-15
Heterocyclyluracils
AU1597197A
(en)
1997-08-22
Thienoquinolines
AU5002897A
(en)
1998-05-29
Gripper-accumulator
AU7623898A
(en)
1998-06-29
Tri-pocket
AU3557397A
(en)
1998-02-25
Double-tau-profile
AU1643797A
(en)
1997-09-25
Repeater-system
AU5016496A
(en)
1997-10-17
Y-spring
None